Maximum Recommended Daily Dosage of Naproxen
The maximum recommended daily dosage of naproxen is 1500 mg per day for limited periods of up to 6 months, with a more typical maximum daily dose of 1000 mg for long-term use. 1
Standard Dosing Guidelines
Naproxen dosing varies based on formulation, indication, and patient factors:
Prescription naproxen (Naprosyn):
Over-the-counter naproxen sodium (Aleve):
- Typical dosing: 220 mg twice daily 2
Dosing by Indication
Rheumatoid arthritis, osteoarthritis, ankylosing spondylitis:
Acute pain, primary dysmenorrhea, acute tendonitis/bursitis:
- Initial dose: 500 mg, followed by 500 mg every 12 hours or 250 mg every 6-8 hours
- First day maximum: 1250 mg
- Subsequent days maximum: 1000 mg 1
Acute gout:
- Starting dose: 750 mg, followed by 250 mg every 8 hours until attack subsides 1
Special Population Considerations
Dose Adjustments Required:
Elderly patients:
Renal impairment:
Hepatic impairment:
- Lower doses recommended 1
Safety Considerations
Gastrointestinal Risk:
The risk of NSAID-related GI complications increases with:
- Higher doses
- Age (particularly >65 years)
- Comorbidities
- Concomitant anticoagulant use (5-6× increased risk) 2
Cardiovascular Risk:
All NSAIDs may increase cardiovascular risk, particularly at higher doses and with prolonged use.
Clinical Pearls
- Naproxen plasma concentrations show a less than proportional increase with increasing dose due to saturation of binding sites on plasma albumin 3
- Some patients may achieve adequate symptom control with a variable dosing regimen that allows for 20-30% lower overall consumption compared to fixed dosing 4
- Morning and evening doses do not need to be equal, and administration more frequently than twice daily generally does not improve response 1
Common Pitfalls to Avoid
Exceeding recommended maximum doses: Never exceed 1500 mg/day even for short periods, and generally limit to 1000 mg/day for maintenance therapy 1
Prolonged use of maximum doses: The 1500 mg/day dose should only be used for limited periods up to 6 months 1
Failure to adjust dosing in high-risk populations: Always consider dose reductions in elderly patients and those with mild renal or hepatic impairment 1
Overlooking formulation differences: Different formulations (tablets, suspension, delayed-release, sodium salt) have different pharmacokinetic properties that may affect onset of action 1